# Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)

> **NCT00128115** · PHASE2 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 83 (actual)

## Conditions studied

- Hip Fracture

## Interventions

- **DRUG:** MK0677

## Key facts

- **NCT ID:** NCT00128115
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-09
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2016-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00128115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00128115, "Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00128115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*